A Systematic Review of Factors Associated with Mortality among Patients with Mycobacterium avium Complex Lung Disease
- PMID: 38003795
- PMCID: PMC10674274
- DOI: 10.3390/pathogens12111331
A Systematic Review of Factors Associated with Mortality among Patients with Mycobacterium avium Complex Lung Disease
Abstract
Purpose: As the number of patients with Mycobacterium avium complex lung disease is significantly increasing worldwide, several studies have focused on the prognostic factors associated with the disease. This systematic review investigated the factors associated with mortality among patients with Mycobacterium avium complex lung disease.
Methods: Two investigators independently identified studies that were designed to determine risk factors for mortality in patients with Mycobacterium avium complex lung disease from PubMed, the Cochrane Register of Control Trial database, and EMBASE (accessed on 25 November 2022).
Results: Of the 1133 titles and abstracts screened, 54 full texts were selected for review, and 15 studies were finally included in this systematic review. The most commonly studied risk factors were advanced age and low body mass index (11 studies for each), followed by male sex (8 studies), hypoalbuminemia (5 studies), and cavity (5 studies). In each study, these factors were mostly associated with increased all-cause mortality among patients with Mycobacterium avium complex lung disease as confirmed via multivariate analysis.
Conclusions: Advanced age, male sex, low body mass index, hypoalbuminemia, and cavity are likely to be the common risk factors for all-cause mortality among patients with Mycobacterium avium complex lung disease, suggesting that patients with these factors need to be carefully monitored.
Keywords: Mycobacterium avium complex; mortality; nontuberculous mycobacterium; predictor; prognosis.
Conflict of interest statement
All authors have stated explicitly that there are no conflict of interest in connection with this article.
Similar articles
-
High mortality in patients with Mycobacterium avium complex lung disease: a systematic review.BMC Infect Dis. 2018 May 3;18(1):206. doi: 10.1186/s12879-018-3113-x. BMC Infect Dis. 2018. PMID: 29724184 Free PMC article.
-
Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.BMJ Open. 2015 Aug 5;5(8):e008058. doi: 10.1136/bmjopen-2015-008058. BMJ Open. 2015. PMID: 26246077 Free PMC article.
-
[Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].Kekkaku. 2013 Mar;88(3):355-71. Kekkaku. 2013. PMID: 23672176 Japanese.
-
Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease.Am J Respir Crit Care Med. 2012 Mar 1;185(5):575-83. doi: 10.1164/rccm.201107-1203OC. Epub 2011 Dec 28. Am J Respir Crit Care Med. 2012. PMID: 22199005
-
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.Cochrane Database Syst Rev. 2020 Jun 10;6(6):CD010004. doi: 10.1002/14651858.CD010004.pub5. Cochrane Database Syst Rev. 2020. PMID: 32521055 Free PMC article.
Cited by
-
Mycobacterium avium Complex-Related Pulmonary Parenchyma Destruction: A Case Report.Cureus. 2025 Apr 11;17(4):e82097. doi: 10.7759/cureus.82097. eCollection 2025 Apr. Cureus. 2025. PMID: 40352038 Free PMC article.
-
Predictive risk factors of treatment-refractory Mycobacterium avium complex lung disease: a single-center retrospective cohort study.Ther Adv Infect Dis. 2025 Apr 11;12:20499361251331676. doi: 10.1177/20499361251331676. eCollection 2025 Jan-Dec. Ther Adv Infect Dis. 2025. PMID: 40292088 Free PMC article.
-
The effects of cyclic peptide [R4W4] in combination with first-line therapy on the survival of Mycobacterium avium.Front Cell Infect Microbiol. 2025 Apr 16;15:1547376. doi: 10.3389/fcimb.2025.1547376. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40308965 Free PMC article.
References
-
- Jhun B.W., Moon S.M., Jeon K., Kwon O.J., Yoo H., Carriere K.C., Huh H.J., Lee N.Y., Shin S.J., Daley C.L., et al. Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: A 15-year follow-up study. Eur. Respir. J. 2020;55:1900798. doi: 10.1183/13993003.00798-2019. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials